Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.


TSXV:MIR - Post by User

<< Previous
Bullboard Posts
Next >>
Post by TanzaniteMotherLodeon Aug 29, 2020 7:01pm
165 Views
Post# 31475886

MIR's test can be transformed to test other COVID-19 markers

MIR's test can be transformed to test other COVID-19 markersMedMira’s RVF® technology platform is very robust and can be transformed to target other SARS-CoV-2-specific analytes (i.e. substance(s) that can be detected using the device). MedMira’s REVEALCOVID-19™ Total Antibody Test is designed to detect total antibodies to SARS-CoV-2 in human specimens. Our product development team continues evaluating other potential SARS-CoV-2-specific analytes to develop new rapid in vitro medical devices, including viral antigen test.

ONCE THIS TRAIN GETS ROLLING IT AIN'T STOPPING

Scroll to bottom of link and check out FAQ #9


https://revealcovid19.com/
<< Previous
Bullboard Posts
Next >>